| no |
title |
author |
magazine |
year |
volume |
issue |
page(s) |
type |
| 1 |
Atrial fibrillation and type 1 diabetes
|
Li, Qianrui
|
|
2017
|
5 |
12 |
p. 936
|
article
|
| 2 |
Atrial fibrillation and type 1 diabetes
|
Xiao, Ying
|
|
2017
|
5 |
12 |
p. 936-937
|
article
|
| 3 |
Atrial fibrillation and type 1 diabetes – Authors' reply
|
Lind, Marcus
|
|
2017
|
5 |
12 |
p. 937
|
article
|
| 4 |
Cardiovascular risk after cessation of growth hormone treatment in people born small for gestational age
|
Pivonello, Rosario
|
|
2017
|
5 |
12 |
p. 930-932
|
article
|
| 5 |
Cardiovascular risk factors and carotid intima media thickness in young adults born small for gestational age after cessation of growth hormone treatment: a 5-year longitudinal study
|
van der Steen, Manouk
|
|
2017
|
5 |
12 |
p. 975-985
|
article
|
| 6 |
Cardiovascular safety and efficacy of the PCSK9 inhibitor evolocumab in patients with and without diabetes and the effect of evolocumab on glycaemia and risk of new-onset diabetes: a prespecified analysis of the FOURIER randomised controlled trial
|
Sabatine, Marc S
|
|
2017
|
5 |
12 |
p. 941-950
|
article
|
| 7 |
Correction to Lancet Diabetes Endocrinol 2016; 4: 963–64
|
|
|
2017
|
5 |
12 |
p. e8
|
article
|
| 8 |
Correction to Lancet Diabetes Endocrinol 2016; 4: 1004–16
|
|
|
2017
|
5 |
12 |
p. e8
|
article
|
| 9 |
Correction to Lancet Diabetes Endocrinol 2017; 5: 864–76
|
|
|
2017
|
5 |
12 |
p. e8
|
article
|
| 10 |
Effect of an intensified multifactorial intervention on cardiovascular outcomes and mortality in type 2 diabetes (J-DOIT3): an open-label, randomised controlled trial
|
Ueki, Kohjiro
|
|
2017
|
5 |
12 |
p. 951-964
|
article
|
| 11 |
Effect of vitamin D supplementation on non-skeletal disorders: a systematic review of meta-analyses and randomised trials
|
Autier, Philippe
|
|
2017
|
5 |
12 |
p. 986-1004
|
article
|
| 12 |
Fat: so much more than just fat
|
Stirrups, Robert
|
|
2017
|
5 |
12 |
p. 940
|
article
|
| 13 |
Good value care: when less is more
|
The Lancet Diabetes & Endocrinology,
|
|
2017
|
5 |
12 |
p. 925
|
article
|
| 14 |
How can we optimise diabetes care in real-world practice?
|
Chan, Juliana C N
|
|
2017
|
5 |
12 |
p. 927-929
|
article
|
| 15 |
How to address non-communicable diseases in urban Africa
|
Hunter-Adams, Jo
|
|
2017
|
5 |
12 |
p. 932-934
|
article
|
| 16 |
Linoleic acid and risk of type 2 diabetes
|
Riccardi, Gabriele
|
|
2017
|
5 |
12 |
p. 929-930
|
article
|
| 17 |
Omega-6 fatty acid biomarkers and incident type 2 diabetes: pooled analysis of individual-level data for 39 740 adults from 20 prospective cohort studies
|
Wu, Jason H Y
|
|
2017
|
5 |
12 |
p. 965-974
|
article
|
| 18 |
PCSK9 inhibition and type 2 diabetes
|
Lotta, Luca A
|
|
2017
|
5 |
12 |
p. 926-927
|
article
|
| 19 |
Research digest: hypoglycaemia and glucose variability
|
Sattar, Naveed
|
|
2017
|
5 |
12 |
p. 938
|
article
|
| 20 |
Top ten research priorities for type 2 diabetes: results from the Diabetes UK–James Lind Alliance Priority Setting Partnership
|
Finer, Sarah
|
|
2017
|
5 |
12 |
p. 935-936
|
article
|
| 21 |
transCampus London–Dresden: a new model for international collaborative research
|
Mitchell, Fiona
|
|
2017
|
5 |
12 |
p. 939
|
article
|
Journal description